Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease - PubMed (original) (raw)
. 2011 May 15;20(10):1966-74.
doi: 10.1093/hmg/ddr077. Epub 2011 Feb 25.
Affiliations
- PMID: 21355049
- DOI: 10.1093/hmg/ddr077
Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease
Guang Shi et al. Hum Mol Genet. 2011.
Abstract
Molecular genetics has linked mitochondrial dysfunction to the pathogenesis of Parkinson's disease by the discovery of rare, inherited mutations in gene products that associate with the mitochondria. Mutations in PTEN-induced kinase-1 (PINK1), which encodes a mitochondrial kinase, and PARKIN, encoding an E3 ubiquitin ligase, are the most frequent causes of recessive Parkinson's disease. Recent functional studies have revealed that PINK1 recruits PARKIN to mitochondria to initiate mitophagy, an important autophagic quality control mechanism that rids the cell of damaged mitochondria. PINK1 is post-translationally processed into a cleaved form whose levels are tightly regulated, although the significance of this processing is unknown. Here we demonstrate that the mitochondrial protease presenilin-associated rhomboid-like (PARL) can affect the proteolytic processing of PINK1 and that normal PINK1 localization and stability requires PARL's catalytic activity. PARL deficiency impairs PARKIN recruitment to mitochondria, suggesting PINK1's processing and localization are important in determining its interaction with PARKIN. We sequenced the PARL gene in Parkinson's disease patients and discovered a novel missense mutation in a functional domain of PARL's N-terminus. This PARL mutant is not sufficient to rescue PARKIN recruitment, suggesting that impaired mitophagy may be an underlying mechanism of disease pathogenesis in patients with PARL mutations.
Similar articles
- Chemical Blockage of the Mitochondrial Rhomboid Protease PARL by Novel Ketoamide Inhibitors Reveals Its Role in PINK1/Parkin-Dependent Mitophagy.
Poláchová E, Bach K, Heuten E, Stanchev S, Tichá A, Lampe P, Majer P, Langer T, Lemberg MK, Stříšovský K. Poláchová E, et al. J Med Chem. 2023 Jan 12;66(1):251-265. doi: 10.1021/acs.jmedchem.2c01092. Epub 2022 Dec 20. J Med Chem. 2023. PMID: 36540942 Free PMC article. - PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis.
Yan C, Gong L, Chen L, Xu M, Abou-Hamdan H, Tang M, Désaubry L, Song Z. Yan C, et al. Autophagy. 2020 Mar;16(3):419-434. doi: 10.1080/15548627.2019.1628520. Epub 2019 Jun 16. Autophagy. 2020. PMID: 31177901 Free PMC article. - Intramembrane protease PARL defines a negative regulator of PINK1- and PARK2/Parkin-dependent mitophagy.
Meissner C, Lorenz H, Hehn B, Lemberg MK. Meissner C, et al. Autophagy. 2015;11(9):1484-98. doi: 10.1080/15548627.2015.1063763. Autophagy. 2015. PMID: 26101826 Free PMC article. - N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
Eldeeb MA, Ragheb MA. Eldeeb MA, et al. Curr Genet. 2020 Aug;66(4):693-701. doi: 10.1007/s00294-020-01062-2. Epub 2020 Mar 10. Curr Genet. 2020. PMID: 32157382 Review. - The three 'P's of mitophagy: PARKIN, PINK1, and post-translational modifications.
Durcan TM, Fon EA. Durcan TM, et al. Genes Dev. 2015 May 15;29(10):989-99. doi: 10.1101/gad.262758.115. Genes Dev. 2015. PMID: 25995186 Free PMC article. Review.
Cited by
- Mitochondrial Quality Control Proteases in Neuronal Welfare.
Levytskyy RM, Germany EM, Khalimonchuk O. Levytskyy RM, et al. J Neuroimmune Pharmacol. 2016 Dec;11(4):629-644. doi: 10.1007/s11481-016-9683-8. Epub 2016 May 2. J Neuroimmune Pharmacol. 2016. PMID: 27137937 Free PMC article. Review. - Single-Cell RNA-Seq of Mouse Dopaminergic Neurons Informs Candidate Gene Selection for Sporadic Parkinson Disease.
Hook PW, McClymont SA, Cannon GH, Law WD, Morton AJ, Goff LA, McCallion AS. Hook PW, et al. Am J Hum Genet. 2018 Mar 1;102(3):427-446. doi: 10.1016/j.ajhg.2018.02.001. Am J Hum Genet. 2018. PMID: 29499164 Free PMC article. - Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency.
Ramonet D, Perier C, Recasens A, Dehay B, Bové J, Costa V, Scorrano L, Vila M. Ramonet D, et al. Cell Death Differ. 2013 Jan;20(1):77-85. doi: 10.1038/cdd.2012.95. Epub 2012 Aug 3. Cell Death Differ. 2013. PMID: 22858546 Free PMC article. - Chemical Blockage of the Mitochondrial Rhomboid Protease PARL by Novel Ketoamide Inhibitors Reveals Its Role in PINK1/Parkin-Dependent Mitophagy.
Poláchová E, Bach K, Heuten E, Stanchev S, Tichá A, Lampe P, Majer P, Langer T, Lemberg MK, Stříšovský K. Poláchová E, et al. J Med Chem. 2023 Jan 12;66(1):251-265. doi: 10.1021/acs.jmedchem.2c01092. Epub 2022 Dec 20. J Med Chem. 2023. PMID: 36540942 Free PMC article. - Common variants of the PINK1 and PARL genes do not confer genetic susceptibility to schizophrenia in Han Chinese.
Li X, Zhang W, Zhang C, Yi Z, Zhang DF, Gong W, Tang J, Wang D, Lu W, Chen X, Fang Y, Yao YG. Li X, et al. Mol Genet Genomics. 2015 Apr;290(2):585-92. doi: 10.1007/s00438-014-0942-1. Epub 2014 Oct 30. Mol Genet Genomics. 2015. PMID: 25354644
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials